0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

BioNTech (BNTX) Valuation Check As Shares Rebound Despite Longer Term Return Weakness [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
See our latest analysis for BioNTech. That recent burst of buying interest comes on top of a 12.86% year to date share price return. However, the 1 year total shareholder return of a 4% decline and 3 year total shareholder return of a 23.74% decline show that near term momentum is building from a weaker longer term base. If BioNTech's move has you looking across the sector, this is a good moment to scan other healthcare stocks that might fit your watchlist next. With shares at around $109.12 and a 12.86% year to date return sitting alongside a 23.74% 3 year decline and mixed profitability, is BioNTech a discounted entry point, or is the market already pricing in future growth? Using a fair value of US$139.29 against the last close at US$109.12, the most followed narrative sees meaningful upside already baked into its model assumptions. Robust pipeline expansion in oncology with multiple late stage (Phase II/III) clinical trials for BNT327 and mRNA cancer immunotherapies acr [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

BioNTech (BNTX) Valuation Check As Shares Rebound Despite Longer Term Return Weakness [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
See our latest analysis for BioNTech. That recent burst of buying interest comes on top of a 12.86% year to date share price return. However, the 1 year total shareholder return of a 4% decline and 3 year total shareholder return of a 23.74% decline show that near term momentum is building from a weaker longer term base. If BioNTech's move has you looking across the sector, this is a good moment to scan other healthcare stocks that might fit your watchlist next. With shares at around $109.12 and a 12.86% year to date return sitting alongside a 23.74% 3 year decline and mixed profitability, is BioNTech a discounted entry point, or is the market already pricing in future growth? Using a fair value of US$139.29 against the last close at US$109.12, the most followed narrative sees meaningful upside already baked into its model assumptions. Robust pipeline expansion in oncology with multiple late stage (Phase II/III) clinical trials for BNT327 and mRNA cancer immunotherapies acr [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS